News Articles for TrivarX

The Bulls N' Bears ASX Runner of the Week is… Entertainment Rewards, after it copped a fat takeover bid from its top shareholder at ten times its market value. Litchfield hit a copper-zinc monster in the Top End, Morella Corp pulled near-perfect rubidium from its WA pegmatites and TrivarX nabbed brain cancer imaging IP, backed by a biotech bigwig, showing small caps can shine amid gold's glare and global jitters.

Alan Campbell has been appointed non-executive chair of Manas Resources.

Bevan Tarratt has been appointed an independent non-executive chair of Emergent Resources.

Thred has announced a capital raising by way of a fully-underwritten, non-renounceable pro-rata entitlement offer at an issue price of $0.004 per new share on the basis of one new share for every t

High Grade Metals is pleased to announce that on 26 February 2018 it completed the acquisition of the issued capital of Austrian Projects Corporation Pty Ltd (ACN 622 432 428).

Dr Adam Darkins has been appointed non-executive deputy chair of Medibio. Dr Darkins earned widespread US and international recognition for his leadership of telehealth programs at the

Medibio has appointed US-based Jack Cosentino as chief executive and managing director.

Perth-based biotechnology company Metavone hopes to list on the ASX next month after raising up to $5 million from investors in an initial public offering.

A world-first mental health check-in that combines wearable technology with an online survey was launched in Perth today.

Retiring Bioprospect chairman Winton Willesee has been replaced by Silvi Elkhouri as director and Peter May as non-executive chairman of the company.